Saving changes...

Done

Error

New Drug Update 2016

New Drug Update 2016

New Drug Update 2016

Bryson Duhon, Pharm.D.
Bryson Duhon, Pharm.D.
on behalf of International Academy Of Compounding Pharmacists

$35.00 $ 35.00 $ 35.00

$35.00 $ 35.00 $ 35.00

$ 35.00 $ 35.00 $ 35.00
$ 35.00 $ 35.00 $ 35.00
Normal Price: $35.00 $35.00

Review:

Launch date: 10 Mar 2017
Expiry Date:

Last updated: 13 Mar 2017

Reference: 171810

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Every year the U.S. Food and Drug Administration approves a number of new drugs for use. In some cases, these new agents represent significant advancements over older, more established treatments. In other instances, however, marketing practices by pharmaceutical companies result in widespread use of some new drugs over less costly, commonly used agents with similar risks and benefits to patients. This seminar will review some recently approved drugs with an emphasis on their pharmacology, clinical efficacy, adverse effects, drug interactions, and monitoring requirements. Attendees will learn practical information about the new drugs presented, which in turn, they can use in their interactions with prescribers and in the care and counseling of their patients.

Objectives

Objectives
At the completion of this activity, pharmacists will be able to:
1. Discuss the basic pharmacology of the new drugs presented and how the pharmacologic actions relate to both therapeutic and adverse effects.
2. Discuss clinically significant adverse effects and drug interactions, and the appropriate dosing and monitoring of the new drugs presented.
3. Discuss the therapeutic role of the new drugs presented as compared to agents already marketed.
At the completion of this activity, technicians will be able to:
1. List the new drugs presented.
2. Describe clinically significant adverse effects and drug interactions, and the appropriate dosing and monitoring of the new drugs presented.
Bryson Duhon, Pharm.D.

Author Information Play Video Bio

Bryson Duhon, Pharm.D.
on behalf of International Academy Of Compounding Pharmacists

The International Academy of Compounding Pharmacists is the recognized authority for information, expertise, and practice standards with regard to pharmacy compounding.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.50 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0154-0000-16-010-H01-P/T

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error